April 8, 2024 News by Patricia Inacio, PhD MS healthcare experts to gather at 38th CMSC meeting in Nashville Renowned experts inĀ multiple sclerosis (MS) healthcare, research, and advocacy will again gather at the annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC), slated this year for May 29 to June 1. The event, now in its 38th edition, will return to the Music City Center, in Nashville,…
November 28, 2023 News by Andrea Lobo, PhD Providers weigh treatment logistics in selecting DMTs for MS patients Certain clinical attributes of disease-modifying therapies (DMTs), such as safety and the medication’s impact on risk of relapse and disability progression, are considered important by healthcare providers in selecting the appropriate treatment for people with multiple sclerosis (MS), according to a new survey study. However, a study experiment also…
December 11, 2018 Columns by Ed Tobias Consensus Lacking on How MS Medications Are Prescribed in the UK Living in the U.S., where disease-modifying therapies (DMTs) seem to be prescribed as a matter of course to people with multiple sclerosis (MS), I was surprised that it doesn’t seem to be the case across the pond in the U.K. An article just published on the Multiple…
November 9, 2018 News by Alberto Molano, PhD Study Highlights Need for Better Engagement Between MS Patients and Healthcare Providers Multiple sclerosis (MS) relapses can be challenging for some patients, and better engagement is needed between patients and their healthcare providers, a study focused on patient experiences has found. The study, titled āRelapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey,ā…
November 2, 2017 News by Ashraf Malhas, PhD #MSParis2017 – Almost Half of MS Patients Fail to Report Relapses, Two Surveys Show Nearly half of multiple sclerosis patients do not always report their relapses to healthcare providers, two surveys indicate. MallinckrodtĀ sponsored the surveys to betterĀ understand patients’ experience with relapses, whichĀ are sudden episodes of new symptoms or worsening of existing symptoms. The company presented the survey results at the 7th joint meeting…
June 23, 2017 News by Patricia Silva, PhD Nurse Advocates for Shared Decision-Making to Treat MS Shared decision-making between patients and their doctors and healthcare providers was considered a critical step in the process of treatingĀ multiple sclerosis (MS), according toĀ an article published in the journal Practical Neurology. The article āShared Decision-making in Multiple Sclerosis Managementā was written by Amy Perrin Ross, a board-certified…
July 28, 2016 News by admin There’s a Lack of Communication by Multiple Sclerosis Healthcare Providers, Study Indicates New research from EnglandĀ indicates that healthcare providers do not communicate enough with their patients about the possible outcomes for their multiple sclerosis (MS). The study, “How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study,“ appeared in the journal PLoS One.